Cancer Nanotechnology, a revolutionary field in medical science, offers promising avenues for the diagnosis, treatment, and monitoring of cancer. At the heart of this innovation lies the application of nanoscale materials and devices tailored to interact with biological systems at the molecular level. Nanoparticles, such as liposomes and dendrimers, serve as versatile carriers for targeted drug delivery, enhancing the efficacy of cancer therapies while minimizing side effects. In diagnostics, nanotechnology enables the development of highly sensitive imaging agents and biosensors. These tools provide unprecedented precision in detecting cancer biomarkers, allowing for early and accurate diagnosis. Moreover, nanoscale materials can be designed to selectively accumulate in tumor tissues, enabling non-invasive imaging and monitoring of treatment responses.
Therapeutically, cancer nanotechnology opens new horizons with approaches like photothermal therapy and gene delivery. Gold nanoparticles, for instance, can be employed to target and heat cancer cells upon exposure to light, providing a localized and controlled treatment. Additionally, nanocarriers loaded with therapeutic genes hold the potential to selectively interfere with cancer cell functions, offering a personalized and targeted treatment strategy. The field of Cancer Nanotechnology is dynamic, continually evolving with ongoing research and technological advancements. Collaboration between researchers, clinicians, and industry stakeholders is crucial to translating these innovations from the laboratory to clinical applications, ultimately improving cancer patient outcomes.
Iron nanoparticles presented superparamagnetic properties and have been widely applied in magnetic force trapping of cells and molecules to accelerate and ease sample preparation. In addition, iron…
The complex tissue architecture with enormous cellular diversity in malignant lesions and the tumor microenvironment, and its transformation with time is a pivotal driver of treatment resistance.…
The main goal of our research was to design, synthesize and characterize the multifunctional nanosystems with a wide potentials for functionalization. We aimed on two kind of materials: the…
Participants can earn 1 CPD credit for each hour of attendance.
Oral and poster slots for original Cancer Nanotechnology work, reviewed by the scientific committee.
Meet nanotechnologists, researchers, scientists and engineers from around the world across three days.
In-person and virtual registrations include an electronic copy of the abstract book.
Plenary lectures from leading voices shaping Cancer Nanotechnology research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Cancer Nanotechnology track is a dedicated stream within World Nano 2027 covering the latest research, innovation, and best practice in Cancer Nanotechnology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Nanotechnology researchers, scientists and engineers, educators and students with an interest in Cancer Nanotechnology are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.
Yes. World Nano 2027 is a hybrid conference — attend the Cancer Nanotechnology track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Attend without presenting.
